CA2985325C - Cyclic compounds for inhibition of toll-like receptor 4 - Google Patents
Cyclic compounds for inhibition of toll-like receptor 4 Download PDFInfo
- Publication number
- CA2985325C CA2985325C CA2985325A CA2985325A CA2985325C CA 2985325 C CA2985325 C CA 2985325C CA 2985325 A CA2985325 A CA 2985325A CA 2985325 A CA2985325 A CA 2985325A CA 2985325 C CA2985325 C CA 2985325C
- Authority
- CA
- Canada
- Prior art keywords
- group
- compound
- mixture
- ethyl
- ene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/12—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyrane Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015-095817 | 2015-05-08 | ||
| JP2015095817 | 2015-05-08 | ||
| PCT/JP2016/064204 WO2016182036A1 (en) | 2015-05-08 | 2016-05-06 | Cyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2985325A1 CA2985325A1 (en) | 2016-11-17 |
| CA2985325C true CA2985325C (en) | 2023-09-26 |
Family
ID=56132991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2985325A Active CA2985325C (en) | 2015-05-08 | 2016-05-06 | Cyclic compounds for inhibition of toll-like receptor 4 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9611244B2 (https=) |
| EP (1) | EP3294706B1 (https=) |
| JP (1) | JP6718884B2 (https=) |
| CN (1) | CN107835800B (https=) |
| AR (1) | AR104539A1 (https=) |
| CA (1) | CA2985325C (https=) |
| EA (1) | EA033083B1 (https=) |
| ES (1) | ES2772703T3 (https=) |
| TW (1) | TW201704206A (https=) |
| UY (1) | UY36675A (https=) |
| WO (1) | WO2016182036A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107835800B (zh) * | 2015-05-08 | 2019-11-26 | 武田药品工业株式会社 | 环状化合物 |
| WO2018047888A1 (ja) | 2016-09-09 | 2018-03-15 | 武田薬品工業株式会社 | 環状化合物 |
| FR3095755A1 (fr) * | 2019-05-10 | 2020-11-13 | Balmes Transplantation | Nouveaux médicaments cytoprotecteurs |
| CN114425054A (zh) * | 2022-01-20 | 2022-05-03 | 中国人民解放军军事科学院军事医学研究院 | 一种蛋白酶体抑制剂Bortezomib在抗辐射损伤中的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2214398C2 (ru) | 1998-03-09 | 2003-10-20 | Такеда Кемикал Индастриз, Лтд. | Производное циклоалкена, способ его получения (варианты), фармацевтическая композиция, способ ингибирования, способ профилактики или лечения |
| DE60045033D1 (de) | 1999-08-06 | 2010-11-11 | Takeda Pharmaceutical | Substituierte aromatische ringverbindungen, verfahren zu ihrer herstellung und ihre anwendung |
| JP2004002370A (ja) * | 2002-04-08 | 2004-01-08 | Takeda Chem Ind Ltd | 重症セプシス予防治療剤 |
| US20060058288A1 (en) | 2002-04-08 | 2006-03-16 | Masayuki Ii | Severe sepsis preventive therapeutic agent |
| KR101327610B1 (ko) | 2005-09-14 | 2013-11-12 | 다이이찌 산쿄 가부시키가이샤 | 치환 시클로알켄 유도체 |
| JP2008260760A (ja) | 2007-03-12 | 2008-10-30 | Daiichi Sankyo Co Ltd | 置換シクロアルケン誘導体を含有する医薬組成物 |
| US20100137787A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Delivery devices for modulating inflammation |
| TWI481401B (zh) | 2010-01-27 | 2015-04-21 | Takeda Pharmaceutical | 藥劑 |
| CN107835800B (zh) * | 2015-05-08 | 2019-11-26 | 武田药品工业株式会社 | 环状化合物 |
-
2016
- 2016-05-06 CN CN201680040064.1A patent/CN107835800B/zh active Active
- 2016-05-06 WO PCT/JP2016/064204 patent/WO2016182036A1/en not_active Ceased
- 2016-05-06 EP EP16729646.6A patent/EP3294706B1/en active Active
- 2016-05-06 EA EA201792469A patent/EA033083B1/ru not_active IP Right Cessation
- 2016-05-06 US US15/148,210 patent/US9611244B2/en active Active
- 2016-05-06 AR ARP160101293A patent/AR104539A1/es unknown
- 2016-05-06 UY UY0001036675A patent/UY36675A/es not_active Application Discontinuation
- 2016-05-06 JP JP2017555812A patent/JP6718884B2/ja active Active
- 2016-05-06 CA CA2985325A patent/CA2985325C/en active Active
- 2016-05-06 ES ES16729646T patent/ES2772703T3/es active Active
- 2016-05-06 TW TW105114092A patent/TW201704206A/zh unknown
- 2016-06-07 US US15/175,292 patent/US9533966B2/en active Active
- 2016-11-21 US US15/356,906 patent/US9828357B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN107835800B (zh) | 2019-11-26 |
| AR104539A1 (es) | 2017-07-26 |
| EA201792469A1 (ru) | 2018-06-29 |
| EP3294706A1 (en) | 2018-03-21 |
| TW201704206A (zh) | 2017-02-01 |
| CN107835800A (zh) | 2018-03-23 |
| US20160326102A1 (en) | 2016-11-10 |
| CA2985325A1 (en) | 2016-11-17 |
| JP6718884B2 (ja) | 2020-07-08 |
| US20170066737A1 (en) | 2017-03-09 |
| WO2016182036A1 (en) | 2016-11-17 |
| BR112017023818A2 (pt) | 2018-07-31 |
| UY36675A (es) | 2016-12-30 |
| US9828357B2 (en) | 2017-11-28 |
| EA033083B1 (ru) | 2019-08-30 |
| JP2018516875A (ja) | 2018-06-28 |
| US9533966B2 (en) | 2017-01-03 |
| US20160326133A1 (en) | 2016-11-10 |
| ES2772703T3 (es) | 2020-07-08 |
| US9611244B2 (en) | 2017-04-04 |
| EP3294706B1 (en) | 2019-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6671456B2 (ja) | 複素環化合物 | |
| AU2015285142B2 (en) | Heterocyclic compounds and their use as Retinoid-related orphan receptor (ROR) gamma-T inhibitors | |
| US10406146B2 (en) | Heterocyclic compound | |
| WO2015068856A1 (en) | Pyrazole for the treatment autoimmune disorders | |
| CA2985325C (en) | Cyclic compounds for inhibition of toll-like receptor 4 | |
| WO2015146929A1 (ja) | 複素環化合物 | |
| CN109923101B (zh) | 环状化合物 | |
| EP3296296A1 (en) | Cyclic compound | |
| BR112017023818B1 (pt) | Composto, e, medicamento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20210331 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 9TH ANNIV.) - STANDARD Year of fee payment: 9 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250424 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250424 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 10TH ANNIV.) - STANDARD Year of fee payment: 10 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260421 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260421 |